Biotechnology Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3172 |  SRZN Surrozen, Inc. - Common Stock | 27.97 USD | +11.26% | -6.05% | +40.41% | +100.93% | 328.75 M USD | ||
| 3211 |  INDP Indaptus Therapeutics, Inc. - Common Stock | 2.37 USD | +4.87% | +12.32% | +18.50% | +24.74% | 315.78 M USD | ||
| 3216 |  AGMB AgomAb Therapeutics NV - ADRs representing one | 9.22 USD | +4.77% | +6.59% | -38.16% | -37.28% | 315.02 M USD | ||
| 3231 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 3.88 USD | +1.31% | +3.47% | -22.71% | +179.14% | 309.64 M USD | ||
| 3244 |  BNTC Benitec Biopharma Inc. - Common Stock | 8.75 USD | -2.67% | -9.89% | -28.92% | -47.32% | 305.22 M USD | ||
| 3247 |  CTNM Contineum Therapeutics, Inc. - Common stock | 13.18 USD | +3.53% | +0.23% | -11.96% | -13.69% | 304.45 M USD | ||
| 3264 |  EYPT EyePoint, Inc. - Common Stock | 3.46 USD | +4.22% | +4.53% | -19.91% | -71.17% | 298.29 M USD | ||
| 3292 |  RCKT Rocket Pharmaceuticals, Inc. - Common Stock | 2.63 USD | +3.54% | -0.75% | -27.35% | -29.11% | 288.71 M USD | ||
| 3300 |  FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.75 USD | +2.18% | +1.63% | -1.83% | -61.26% | 286.11 M USD | ||
| 3309 |  ABEO Abeona Therapeutics Inc. - Common Stock | 4.96 USD | -2.36% | -2.55% | -12.98% | -12.83% | 283.63 M USD | ||
| 3321 |  LRMR Larimar Therapeutics, Inc. - Common Stock | 2.70 USD | -1.82% | -13.18% | -29.32% | -40.40% | 280.48 M USD | ||
| 3327 |  XFOR X4 Pharmaceuticals, Inc. - Common Stock | 2.79 USD | -0.71% | -2.45% | -22.50% | -6.06% | 276.62 M USD | ||
| 3333 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 3.42 USD | -0.58% | -13.85% | -48.96% | -72.51% | 274.20 M USD | ||
| 3334 |  VNDA Vanda Pharmaceuticals Inc. - Common Stock | 4.53 USD | -0.66% | -6.60% | -12.88% | -18.08% | 273.90 M USD | ||
| 3350 |  QSI Quantum-Si Incorporated - Class A Common Stock | 1.22 USD | -4.69% | -11.59% | +62.67% | -32.22% | 267.04 M USD | ||
| 3353 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 1.91 USD | -1.55% | -3.54% | -19.41% | +15.06% | 266.51 M USD | ||
| 3357 |  IPSC Century Therapeutics, Inc. - Common Stock | 1.46 USD | +14.06% | -11.52% | -28.08% | +143.33% | 264.37 M USD | ||
| 3360 |  LXEO Lexeo Therapeutics, Inc. - Common Stock | 3.21 USD | -3.02% | -12.30% | -27.05% | -61.09% | 263.37 M USD | ||
| 3362 |  SABS SAB Biotherapeutics, Inc. - Common Stock | 2.89 USD | +0.35% | -7.37% | -16.95% | +13.78% | 262.95 M USD | ||
| 3372 |  LCTX Lineage Cell Therapeutics, Inc. Common Stock | 1.03 USD | +8.42% | +7.29% | +0.98% | -40.12% | 260.49 M USD |
Nachrichten Biotechnology Stocks
Pharvaris: HAE-Medikament zeigt in Lancet-Studie schnellere Symptomlinderung
Kymera Therapeutics: Raymond James startet Coverage mit „Outperform“-Rating
Raymond James startet Coverage für Nektar-Aktie mit "Market Perform"
Raymond James nimmt Coverage für Palisade Bio mit "Outperform" auf
Raymond James bestätigt Liquidia-Rating trotz rechtlicher Unsicherheiten
Ginkgo Bioworks gewährt NSF X-Labs Zugang zu autonomem Labor
AbCellera präsentiert Phase-1/2-Daten zu Medikamentenkandidaten gegen Menopause-Beschwerden
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |